NACHWEIS VON INFLUENZA-A-VIRUS

European patent · EP2016185 · In force

Register entry

Publication number
EP2016185
Application number
EP07760491
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 11, 2007
Published
Jan 21, 2009
Granted
Nov 19, 2014
Protection ends at the latest
Apr 10, 2027
Next annual fee due
Apr 30, 2027
IPC classes
C12P 19/34 (2006.01)
Priority
US 401648 11.04.2006
US 459789 25.07.2006
PCT application
PCT/US2007/066440 11.04.2007
PCT publication
WO2007/121247 25.10.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Mar 31, 2022

    Address changed

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich → Schaad Balass Menzl & Partner AG, Patent- und Markenanwälte, Bellerivestrasse 20, Postfach, 8034 Zürich

    Published in Swissreg on 31.03.2022

  6. Feb 14, 2015

    Agent entered

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in Swissreg on 14.02.2015

  7. Nov 19, 2014

    Granted

    Published in Swissreg on 19.11.2014

Parties

Inventor

ESPY, Mark J.

Rochester, Minnesota 55906, US

SMITH, Thomas F.

Rochester, Minnesota 55902, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.